You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LUCEMYRA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lucemyra patents expire, and what generic alternatives are available?

Lucemyra is a drug marketed by Uswm and is included in one NDA.

The generic ingredient in LUCEMYRA is lofexidine hydrochloride. Four suppliers are listed for this compound. Additional details are available on the lofexidine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lucemyra

A generic version of LUCEMYRA was approved as lofexidine hydrochloride by INDOCO on August 20th, 2024.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LUCEMYRA?
  • What are the global sales for LUCEMYRA?
  • What is Average Wholesale Price for LUCEMYRA?
Summary for LUCEMYRA
Drug patent expirations by year for LUCEMYRA
Drug Prices for LUCEMYRA

See drug prices for LUCEMYRA

Recent Clinical Trials for LUCEMYRA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yale UniversityPhase 1/Phase 2
BioXcel Therapeutics IncPhase 1/Phase 2
National Institute on Drug Abuse (NIDA)Phase 1/Phase 2

See all LUCEMYRA clinical trials

US Patents and Regulatory Information for LUCEMYRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Uswm LUCEMYRA lofexidine hydrochloride TABLET;ORAL 209229-001 May 16, 2018 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.